Radiotherapy Combined with Systemic Therapy Versus Systemic Therapy for Oligometastatic UTUCs

Clinical trial NCT06652022 · RECRUITING

Trial details

NCT number: NCT06652022
Sponsor: Peking University First Hospital
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Oligometastatic Disease Ureter Cancer Renal Pelvic Carcinoma

Start date: 2022-01-01
Primary completion: 2026-12-31
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.